Drug Shortage Report for 5% DEXTROSE AND 0.45% SODIUM CHLORIDE
Report ID | 200398 |
Drug Identification Number | 00038903 |
Brand name | 5% DEXTROSE AND 0.45% SODIUM CHLORIDE |
Common or Proper name | Dextrose and Sodium Chloride Injection USP |
Company Name | ICU MEDICAL CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM CHLORIDE DEXTROSE |
Strength(s) | 4.5MG 50MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1000 mL |
ATC code | B05BB |
ATC description | I.V. SOLUTIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2023-09-18 |
Actual start date | |
Estimated end date | 2023-10-30 |
Actual end date | 2023-09-06 |
Shortage status | Avoided shortage |
Updated date | 2023-09-06 |
Company comments | Shortage was avoided. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2600 BOUL ALFRED-NOBEL, SUITE 100 SAINT LAURENT, QUEBEC CANADA H4S 0A9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2023-09-06 | French | Compare |
v3 | 2023-09-06 | English | Compare |
v2 | 2023-07-28 | French | Compare |
v1 | 2023-07-28 | English | Compare |
Showing 1 to 4 of 4